Sort
10,766 grants matching “checkpoint inhibitor”
Potentiation of Immunotherapy with targeted nanoporphyrin in bladder cancer
$0Chong-Xian Pan · Va Boston Health Care System · I01 · FY2019 · VA
The role of eosinophils and oxidative stress in esophageal malignancy
$0Yash Choksi · Veterans Health Administration · IK2 · FY2020 · VA
Impact of N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on the Progression of Melanoma
$0Joanne Kramer Tobacman · Jesse Brown Va Medical Center · I01 · FY2023 · VA
Combined inhibition of PLK1 and NOTCH for melanoma management
$0Nihal Ahmad · Wm S. Middleton Memorial Veterans Hosp · I01 · FY2025 · VA
Impact of N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on the Progression of Melanoma
$0Joanne Kramer Tobacman · Jesse Brown Va Medical Center · I01 · FY2024 · VA
Programming Durable Immune Responses in Lung Cancer
$0Sherven Sharma · Va Greater Los Angeles Healthcare System · I01 · FY2017 · VA
Overcoming BRAF and MEK Inhibitors Resistance in Advanced Melanoma
$0Niramol Savaraj · Miami Va Health Care System · I01 · FY2017 · VA
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targ
$0Basic Sciences · Z01 · FY2003 · BC
Overcoming BRAF and MEK Inhibitors Resistance in Advanced Melanoma
$0Niramol Savaraj · Miami Va Health Care System · I01 · FY2016 · VA
Defining the role of the EGFR in MHC expression and anti-tumor immune responses.
$0Brian P Pollack · Veterans Health Administration · I01 · FY2016 · VA
Mechanisms of Response to Reflux-Induced Oxidative Stress in Barrett's Esophagus
$0Stuart Jon Spechler · Va North Texas Health Care System · I01 · FY2016 · VA
Glycocalyx Targeting and Augmenting Cellular Immunity in Lung Cancer
$0Mark M Fuster · Va San Diego Healthcare System · I01 · FY2023 · VA
Cytomegalovirus-based Immunotherapy for Prostate Cancer
$0Richard B Alexander · Baltimore Va Medical Center · I01 · FY2016 · VA
Regulation of cutaneous immune function and anti-tumor immune responses by PPARgamma-mediated transrepressive signaling
$0Raymond L Konger · Rlr Va Medical Center · I01 · FY2020 · VA
Autoinflammation in Human Melanoma
$0Mayumi Fujita · Va Eastern Colorado Health Care System · I01 · FY2020 · VA
Translational application of mouse models of melanoma brain metastases
$0Suzie Chen · Va New Jersey Health Care System · I01 · FY2023 · VA
Epigenetic Regulation of Immune Evasion in Bladder Cancer
$0Joshua James Meeks · Jesse Brown Va Medical Center · I01 · FY2023 · VA
Design of Drugs Against Cancer and Viral Diseases
$0Basic Sciences · Z01 · FY2002 · BC
Death Receptors In Immune Cell Homeostasis
$0Arthritis, Musculoskeletal, Skin Dis · Z01 · FY2002 · AR
Mechanisms Of Nucleic Acid Enzymes--pol Beta And Mammali
$0Environmental Health Sciences · Z01 · FY2002 · ES
Preclinical investigation of PI3K inhibition and immune checkpoint blockade combination therapy for treatment of Merkel cell carcinoma using humanized mouse models
$0Ling Gao · Veterans Health Administration · I01 · FY2023 · VA
BLR&D Merit Review Research Career Scientist (RCS) Award (IK6)
$0Ann Richmond · Veterans Health Administration · IK6 · FY2023 · VA
Potentiation of Immunotherapy with targeted nanoporphyrin in bladder cancer
$0Chong-Xian Pan · Va Northern California Health Care Sys · I01 · FY2018 · VA
BLR&D Research Career Scientist Award Application
$0Qizhi C. Yao · Michael E Debakey Va Medical Center · IK6 · FY2025 · VA
Role of ATRX, a chromatin remodeler, in immunotherapy response
$0Daniel Sanghoon Shin · Va Greater Los Angeles Healthcare System · I01 · FY2024 · VA